632 employees
Valneva is a specialty vaccine company that develops prophylactic vaccines to treat infectious diseases.
2013
$50M
from 3 investors over 3 rounds
Valneva raised $50M on August 17, 2023
Investors: OrbiMed Advisors
Valneva raised $20M on April 26, 2022
Valneva raised $27M on February 21, 2022
Investors: Scottish Enterprise